Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.14 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 40.45.
Market Cap
8.14T
Revenue
4.59T
Profits
201.3B
PE Ratio
40.45
Profit Margin
4.39%
Dividend Yield
0.44%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 948.95B | -1.67% | 2,407,747 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 536.54B | -0.28% | 5,667,526 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 380.57B | 1.16% | 5,861,011 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 343.21B | -0.51% | 3,893,901 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 285.64B | 0.42% | 8,310,665 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 276.14B | -1.26% | 2,039,395 | 60.44B |
| 7 | NVS | Novartis AG | 263.07B | -1.51% | 1,472,808 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 191.64B | -2.61% | 17,155,204 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 179.15B | -2.42% | 1,778,659 | 45.20B |
| 10 | AMGN | Amgen Inc. | 177.16B | -0.26% | 1,558,576 | 37.22B |
| 11 | GILD | Gilead Sciences, Inc. | 158.39B | -2.69% | 8,081,848 | 29.74B |
| 12 | ABT | Abbott Laboratories | 151.49B | -0.92% | 10,301,202 | 45.13B |
| 13 | PFE | Pfizer Inc. | 145.62B | -0.31% | 31,291,643 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 142.48B | -2.42% | 3,985,361 | 10.58B |
| 15 | DHR | Danaher Corporation | 124.65B | -2.09% | 2,913,961 | 24.78B |
| 16 | CVS | CVS Health Corporation | 114.20B | -1.24% | 5,652,046 | 405.62B |
| 17 | SYK | Stryker Corporation | 112.44B | -2.06% | 2,995,502 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 111.21B | -0.89% | 13,740,152 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 107.89B | -3.04% | 1,147,006 | 12.22B |
| 20 | SNY | Sanofi | 102.61B | -0.37% | 1,963,692 | 54.60B |
| 21 | GSK | GSK plc | 97.92B | -0.63% | 2,941,989 | 43.29B |
| 22 | MDT | Medtronic plc | 94.69B | -0.31% | 14,441,700 | 35.48B |
| 23 | MCK | McKesson Corporation | 88.56B | 0.27% | 885,423 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 84.48B | -3.38% | 2,189,127 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 81.49B | -0.97% | 2,002,639 | 76.39B |
| 26 | CI | The Cigna Group | 72.14B | -0.54% | 1,307,193 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 70.87B | -0.63% | 21,680,964 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 61.34B | 0.38% | 1,077,454 | 14.92B |
| 29 | COR | Cencora, Inc. | 51.53B | 0.06% | 1,477,373 | 328.68B |
| 30 | EW | Edwards Lifesciences Corporation | 50.47B | -0.57% | 6,316,331 | 6.30B |
| 31 | ARGX | argenx SE | 50.25B | -4.06% | 359,241 | 4.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 47.92B | -0.07% | 2,378,766 | 28.34B |
| 33 | CAH | Cardinal Health, Inc. | 45.64B | -0.14% | 1,786,944 | 250.74B |
| 34 | MDLN | Medline Inc. | 43.60B | -7.16% | 18,085,427 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 43.45B | -2.82% | 669,211 | 4.45B |
| 36 | BDX | Becton, Dickinson and Company | 39.80B | -0.62% | 2,693,468 | 22.23B |
| 37 | HUM | Humana Inc. | 38.53B | -2.26% | 919,855 | 137.20B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 38.52B | -4.50% | 10,282,223 | 17.35B |
| 39 | HLN | Haleon plc | 38.31B | -1.58% | 6,473,258 | 14.85B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.20B | -3.22% | 1,042,605 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 38.14B | -0.68% | 3,020,838 | 7.23B |
| 42 | WAT | Waters Corporation | 36.52B | -1.65% | 665,547 | 3.77B |
| 43 | RVMD | Revolution Medicines, Inc. | 32.17B | -7.56% | 3,750,371 | - |
| 44 | ZTS | Zoetis Inc. | 32.02B | -1.51% | 7,670,244 | 9.53B |
| 45 | ALC | Alcon Inc. | 31.62B | -2.16% | 2,270,422 | 10.63B |
| 46 | RPRX | Royalty Pharma plc | 31.10B | -2.12% | 3,567,950 | 2.44B |
| 47 | ONC | BeOne Medicines AG | 30.54B | -1.78% | 247,197 | 5.70B |
| 48 | NTRA | Natera, Inc. | 30.45B | -2.78% | 1,174,919 | 2.50B |
| 49 | IQV | IQVIA Holdings Inc. | 30.15B | -3.31% | 1,679,542 | 16.63B |
| 50 | VEEV | Veeva Systems Inc. | 29.86B | -3.03% | 3,792,499 | 3.20B |
| 51 | CNC | Centene Corporation | 29.62B | -3.24% | 3,824,718 | 178.33B |
| 52 | DXCM | DexCom, Inc. | 28.34B | -1.90% | 3,751,450 | 4.82B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 28.20B | -1.12% | 3,234,405 | 20.98B |
| 54 | BIIB | Biogen Inc. | 27.88B | -1.77% | 1,098,094 | 9.94B |
| 55 | RMD | ResMed Inc. | 26.52B | -1.94% | 1,734,522 | 5.54B |
| 56 | ILMN | Illumina, Inc. | 24.59B | -1.13% | 2,132,768 | 4.39B |
| 57 | PHG | Koninklijke Philips N.V. | 24.37B | -2.49% | 3,045,805 | 20.34B |
| 58 | MTD | Mettler-Toledo International Inc. | 23.64B | -1.15% | 181,525 | 4.09B |
| 59 | UTHR | United Therapeutics Corporation | 22.92B | -0.84% | 438,096 | 3.17B |
| 60 | BNTX | BioNTech SE | 22.54B | -2.79% | 968,300 | 3.23B |
| 61 | INSM | Insmed Incorporated | 22.48B | -2.17% | 2,406,078 | 819.56M |
| 62 | WST | West Pharmaceutical Services, Inc. | 22.05B | -1.31% | 707,805 | 3.22B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.38B | 0.50% | 678,508 | 11.28B |
| 64 | LH | Labcorp Holdings Inc. | 21.13B | 0.32% | 506,968 | 14.14B |
| 65 | STE | STERIS plc | 20.47B | -0.62% | 600,346 | 5.94B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.32B | -2.89% | 5,069,600 | 8.26M |
| 67 | INCY | Incyte Corporation | 18.43B | -3.50% | 2,021,700 | 5.36B |
| 68 | VTRS | Viatris Inc. | 18.27B | -0.76% | 8,974,203 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 18.11B | -0.91% | 5,690,072 | 2.23B |
| 70 | GH | Guardant Health, Inc. | 17.26B | 0.80% | 2,089,188 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.20B | 0.98% | 2,602,072 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 15.57B | -3.83% | 1,039,455 | 3.10B |
| 73 | GMAB | Genmab A/S | 14.76B | -6.29% | 3,617,150 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 14.19B | -2.80% | 1,393,134 | 4.44B |
| 75 | THC | Tenet Healthcare Corporation | 14.09B | -3.82% | 1,437,342 | 21.46B |
| 76 | ASND | Ascendis Pharma A/S | 13.45B | -1.01% | 529,856 | 998.25M |
| 77 | SOLV | Solventum Corporation | 13.24B | 0.78% | 2,372,966 | 8.26B |
| 78 | MEDP | Medpace Holdings, Inc. | 12.73B | -1.30% | 298,812 | 2.68B |
| 79 | SNN | Smith & Nephew plc | 12.56B | -0.41% | 1,289,908 | 6.16B |
| 80 | PEN | Penumbra, Inc. | 12.54B | -0.07% | 397,338 | 1.45B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 12.51B | -2.26% | 4,697,517 | 579.96M |
| 82 | BTSG | BrightSpring Health Services, Inc. | 12.20B | -1.07% | 1,886,431 | 13.65B |
| 83 | EXEL | Exelixis, Inc. | 12.20B | -3.46% | 3,037,132 | 2.38B |
| 84 | DVA | DaVita Inc. | 12.06B | -1.01% | 925,201 | 13.84B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.06B | -3.20% | 2,081,108 | 1.06B |
| 86 | ALGN | Align Technology, Inc. | 11.94B | -1.81% | 902,258 | 4.10B |
| 87 | ELAN | Elanco Animal Health Incorporated | 11.80B | -0.17% | 3,717,994 | 4.89B |
| 88 | COO | The Cooper Companies, Inc. | 11.61B | -1.16% | 4,196,147 | 4.15B |
| 89 | SMMT | Summit Therapeutics Inc. | 11.53B | -5.41% | 10,043,868 | - |
| 90 | RGC | Regencell Bioscience Holdings Limited | 11.47B | -4.22% | 77,943 | - |
| 91 | AXSM | Axsome Therapeutics, Inc. | 11.43B | -3.51% | 603,784 | 708.24M |
| 92 | RVTY | Revvity, Inc. | 11.20B | -0.13% | 1,421,719 | 2.90B |
| 93 | FMS | Fresenius Medical Care AG | 11.16B | -2.33% | 2,280,127 | 22.32B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.14B | -1.73% | 1,888,175 | 3.58B |
| 95 | GMED | Globus Medical, Inc. | 10.62B | -1.92% | 1,766,191 | 3.10B |
| 96 | ICLR | ICON Public Limited Company | 10.53B | -0.34% | 1,244,128 | 8.25B |
| 97 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.44B | -5.90% | 427,197 | 1.13B |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 10.31B | -3.11% | 2,708,056 | 3.24B |
| 99 | EHC | Encompass Health Corporation | 10.07B | -1.15% | 731,162 | 6.07B |
| 100 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.98B | -5.82% | 2,010,116 | 622.01M |
| 101 | PODD | Insulet Corporation | 9.87B | -3.85% | 1,121,237 | 2.90B |
| 102 | BAX | Baxter International Inc. | 9.65B | 1.52% | 5,980,506 | 11.32B |
| 103 | CYTK | Cytokinetics, Incorporated | 9.63B | -3.76% | 1,487,883 | 105.82M |
| 104 | ENSG | The Ensign Group, Inc. | 9.60B | 0.35% | 443,865 | 5.27B |
| 105 | MOH | Molina Healthcare, Inc. | 9.37B | -1.85% | 899,831 | 43.10B |
| 106 | MASI | Masimo Corporation | 9.36B | 0.08% | 1,021,275 | 1.56B |
| 107 | TEM | Tempus AI, Inc. | 8.91B | -6.02% | 6,390,868 | 1.36B |
| 108 | BRKR | Bruker Corporation | 8.72B | -1.93% | 2,537,084 | 3.46B |
| 109 | HSIC | Henry Schein, Inc. | 8.66B | -0.47% | 1,492,962 | 13.38B |
| 110 | KRYS | Krystal Biotech, Inc. | 8.64B | -1.64% | 334,075 | 417.30M |
| 111 | UHS | Universal Health Services, Inc. | 8.63B | -1.48% | 1,094,797 | 17.76B |
| 112 | CRL | Charles River Laboratories International, Inc. | 8.42B | -4.00% | 752,223 | 4.03B |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 8.19B | 0.22% | 405,391 | 2.59B |
| 114 | HALO | Halozyme Therapeutics, Inc. | 7.86B | -2.73% | 1,741,056 | 1.51B |
| 115 | TECH | Bio-Techne Corporation | 7.79B | -2.01% | 2,282,426 | 1.21B |
| 116 | CORT | Corcept Therapeutics Incorporated | 7.64B | 1.08% | 984,562 | 769.10M |
| 117 | IBRX | ImmunityBio, Inc. | 7.57B | -0.14% | 13,723,361 | 140.98M |
| 118 | HQY | HealthEquity, Inc. | 7.39B | -2.54% | 1,068,559 | 1.34B |
| 119 | QGEN | Qiagen N.V. | 7.38B | -1.35% | 1,849,335 | 2.10B |
| 120 | NUVL | Nuvalent, Inc. | 7.22B | -1.78% | 1,723,225 | - |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 7.19B | -23.00% | 1,562,428 | 7.46M |
| 122 | ATR | AptarGroup, Inc. | 7.16B | -0.18% | 452,292 | 3.87B |
| 123 | ALKS | Alkermes plc | 6.89B | -2.25% | 2,145,802 | 1.56B |
| 124 | PCVX | Vaxcyte, Inc. | 6.85B | -3.07% | 1,575,619 | - |
| 125 | RGEN | Repligen Corporation | 6.83B | -1.60% | 769,571 | 763.34M |
| 126 | LEGN | Legend Biotech Corporation | 6.74B | 42.22% | 14,682,453 | 1.14B |
| 127 | GKOS | Glaukos Corporation | 6.50B | 7.43% | 1,866,962 | 551.35M |
| 128 | GRFS | Grifols, S.A. | 6.50B | -1.42% | 583,189 | 8.58B |
| 129 | HIMS | Hims & Hers Health, Inc. | 6.37B | -0.90% | 14,761,180 | 2.37B |
| 130 | OSCR | Oscar Health, Inc. | 6.37B | -7.97% | 8,536,575 | 13.30B |
| 131 | IMVT | Immunovant, Inc. | 6.35B | -5.90% | 1,926,454 | - |
| 132 | LNTH | Lantheus Holdings, Inc. | 6.27B | -0.85% | 986,711 | 1.55B |
| 133 | CNTA | Centessa Pharmaceuticals plc | 6.17B | 0.10% | 1,133,628 | 15.00M |
| 134 | AVTR | Avantor, Inc. | 6.14B | -2.18% | 10,131,078 | 6.55B |
| 135 | SYRE | Spyre Therapeutics, Inc. | 6.01B | -1.96% | 814,547 | - |
| 136 | PTGX | Protagonist Therapeutics, Inc. | 6.00B | -1.78% | 723,580 | 74.06M |
| 137 | APGE | Apogee Therapeutics, Inc. | 5.90B | -0.67% | 1,113,648 | - |
| 138 | KYMR | Kymera Therapeutics, Inc. | 5.86B | -9.15% | 837,115 | 51.48M |
| 139 | ABVX | ABIVAX Société Anonyme | 5.86B | -44.10% | 16,129,949 | 5.67M |
| 140 | PACS | PACS Group, Inc. | 5.84B | 3.85% | 936,699 | 5.43B |
| 141 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.78B | -4.01% | 524,717 | 217.17M |
| 142 | PTCT | PTC Therapeutics, Inc. | 5.66B | -7.55% | 1,238,385 | 827.11M |
| 143 | MIRM | Mirum Pharmaceuticals, Inc. | 5.62B | -4.32% | 661,212 | 569.61M |
| 144 | COGT | Cogent Biosciences, Inc. | 5.60B | -5.89% | 4,267,054 | - |
| 145 | TFX | Teleflex Incorporated | 5.54B | -1.83% | 652,447 | 2.13B |
| 146 | CHE | Chemed Corporation | 5.52B | -1.33% | 168,872 | 2.54B |
| 147 | SRRK | Scholar Rock Holding Corporation | 5.35B | -5.72% | 1,104,784 | - |
| 148 | BLCO | Bausch + Lomb Corporation | 5.34B | -2.66% | 590,211 | 5.21B |
| 149 | BLTE | Belite Bio, Inc | 5.31B | -8.21% | 396,642 | - |
| 150 | TGTX | TG Therapeutics, Inc. | 5.19B | -2.06% | 1,528,243 | 700.35M |
| 151 | STVN | Stevanato Group S.p.A. | 5.13B | -0.42% | 153,426 | 1.39B |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.06B | -2.08% | 1,899,539 | 7.50M |
| 153 | CRSP | CRISPR Therapeutics AG | 5.02B | -4.00% | 1,372,395 | 4.10M |
| 154 | LQDA | Liquidia Corporation | 4.90B | -6.19% | 2,293,346 | 288.07M |
| 155 | CGON | CG Oncology, Inc. | 4.90B | -6.25% | 1,164,640 | 5.07M |
| 156 | CAI | Caris Life Sciences, Inc. | 4.67B | 0.43% | 2,572,712 | 907.29M |
| 157 | LGND | Ligand Pharmaceuticals Incorporated | 4.67B | 1.35% | 185,122 | 274.48M |
| 158 | HNGE | Hinge Health, Inc. | 4.53B | -4.01% | 1,777,583 | 646.34M |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.46B | -8.81% | 1,057,923 | 1.34M |
| 160 | CELC | Celcuity Inc. | 4.46B | -25.65% | 5,688,472 | - |
| 161 | TWST | Twist Bioscience Corporation | 4.37B | 3.37% | 1,088,100 | 409.48M |
| 162 | BLLN | BillionToOne, Inc. | 4.34B | 3.44% | 930,929 | 354.54M |
| 163 | SHC | Sotera Health Company | 4.28B | -3.31% | 3,366,145 | 1.19B |
| 164 | RDNT | RadNet, Inc. | 4.27B | 2.68% | 712,824 | 2.14B |
| 165 | ERAS | Erasca, Inc. | 4.19B | -2.46% | 7,131,076 | - |
| 166 | MANE | Veradermics, Incorporated | 4.10B | -3.28% | 428,380 | - |
| 167 | AMRX | Amneal Pharmaceuticals, Inc. | 4.04B | -1.94% | 2,073,972 | 3.05B |
| 168 | LIVN | LivaNova PLC | 4.03B | -0.65% | 836,289 | 1.43B |
| 169 | EWTX | Edgewise Therapeutics, Inc. | 4.01B | -7.48% | 2,816,357 | - |
| 170 | TVTX | Travere Therapeutics, Inc. | 3.99B | -4.62% | 2,533,694 | 536.20M |
| 171 | WAY | Waystar Holding Corp. | 3.99B | -5.02% | 2,243,052 | 1.16B |
| 172 | DOCS | Doximity, Inc. | 3.93B | -4.61% | 3,202,487 | 644.86M |
| 173 | TXG | 10x Genomics, Inc. | 3.90B | 3.79% | 3,094,910 | 638.78M |
| 174 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | - | 1,610,408 | 596.96M |
| 175 | VCYT | Veracyte, Inc. | 3.81B | -0.79% | 1,783,669 | 541.74M |
| 176 | NVST | Envista Holdings Corporation | 3.73B | -1.84% | 1,625,730 | 2.81B |
| 177 | NAMS | NewAmsterdam Pharma Company N.V. | 3.71B | -0.25% | 1,998,952 | 22.57M |
| 178 | MMSI | Merit Medical Systems, Inc. | 3.63B | -1.87% | 802,454 | 1.54B |
| 179 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.61B | -3.12% | 645,577 | 754.05M |
| 180 | ACAD | ACADIA Pharmaceuticals Inc. | 3.58B | -2.93% | 1,235,977 | 1.10B |
| 181 | OGN | Organon & Co. | 3.51B | 0.15% | 2,567,581 | 6.16B |
| 182 | IRTC | iRhythm Holdings, Inc. | 3.47B | -3.36% | 652,384 | 787.85M |
| 183 | MMED | MiniMed Group, Inc. | 3.45B | 2.50% | 1,062,604 | 2.99B |
| 184 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.44B | -5.53% | 978,146 | 18.07M |
| 185 | RLAY | Relay Therapeutics, Inc. | 3.42B | 10.10% | 11,483,091 | 10.68M |
| 186 | VKTX | Viking Therapeutics, Inc. | 3.40B | -6.33% | 2,761,386 | - |
| 187 | ORKA | Oruka Therapeutics, Inc. | 3.33B | 0.40% | 1,161,740 | - |
| 188 | ICUI | ICU Medical, Inc. | 3.26B | -0.88% | 292,789 | 2.16B |
| 189 | OPCH | Option Care Health, Inc. | 3.23B | 0.39% | 1,616,357 | 5.67B |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.21B | -0.63% | 778,647 | 2.23B |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.11B | -6.93% | 3,189,198 | 56.99M |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.08B | -2.76% | 186,235 | 803.79M |
| 193 | WRBY | Warby Parker Inc. | 3.08B | 2.91% | 2,439,506 | 890.57M |
| 194 | RCUS | Arcus Biosciences, Inc. | 3.08B | -4.67% | 1,179,364 | 236.00M |
| 195 | DNLI | Denali Therapeutics Inc. | 3.07B | -5.19% | 1,764,050 | - |
| 196 | ITGR | Integer Holdings Corporation | 3.07B | 0.17% | 336,929 | 1.86B |
| 197 | HAE | Haemonetics Corporation | 3.02B | -1.26% | 922,246 | 1.33B |
| 198 | LFST | LifeStance Health Group, Inc. | 3.01B | -2.27% | 2,153,079 | 1.49B |
| 199 | KLRA | Kailera Therapeutics, Inc. | 2.93B | -2.55% | 443,627 | - |
| 200 | BEAM | Beam Therapeutics Inc. | 2.88B | -7.00% | 1,771,031 | 164.01M |
| 201 | BKD | Brookdale Senior Living Inc. | 2.88B | -1.15% | 5,079,907 | 3.00B |
| 202 | NHC | National HealthCare Corporation | 2.86B | 2.20% | 111,703 | 1.53B |
| 203 | DYN | Dyne Therapeutics, Inc. | 2.85B | -7.46% | 1,881,578 | - |
| 204 | ALHC | Alignment Healthcare, Inc. | 2.82B | 2.56% | 7,607,521 | 4.26B |
| 205 | GPCR | Structure Therapeutics Inc. | 2.64B | -3.53% | 853,965 | - |
| 206 | PRVA | Privia Health Group, Inc. | 2.62B | -2.39% | 884,436 | 2.25B |
| 207 | ARQT | Arcutis Biotherapeutics, Inc. | 2.60B | -3.17% | 2,311,570 | 415.62M |
| 208 | IRON | Disc Medicine, Inc. | 2.60B | -5.52% | 415,536 | - |
| 209 | GRAL | GRAIL, Inc. | 2.57B | -6.99% | 1,587,127 | 156.12M |
| 210 | SUPN | Supernus Pharmaceuticals, Inc. | 2.56B | -1.54% | 711,341 | 776.83M |
| 211 | ALMS | Alumis Inc. | 2.55B | -1.43% | 1,510,821 | 8.40M |
| 212 | HTFL | HeartFlow, Inc. | 2.55B | -4.68% | 727,002 | 191.42M |
| 213 | DFTX | Definium Therapeutics, Inc. | 2.49B | -4.99% | 2,286,345 | - |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 2.47B | -2.72% | 877,943 | 535.08M |
| 215 | GRDN | Guardian Pharmacy Services, Inc. | 2.46B | -0.87% | 499,599 | 1.46B |
| 216 | IDYA | IDEAYA Biosciences, Inc. | 2.45B | -3.70% | 948,103 | 225.27M |
| 217 | ADPT | Adaptive Biotechnologies Corporation | 2.42B | -0.59% | 1,631,598 | 295.41M |
| 218 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | -7.26% | 728,549 | - |
| 219 | GMRS | GMR Solutions Inc. | 2.37B | -8.22% | 632,752 | 5.74B |
| 220 | TMDX | TransMedics Group, Inc. | 2.37B | 1.36% | 1,382,885 | 635.89M |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.27B | -4.11% | 918,408 | 865.00K |
| 222 | ACHC | Acadia Healthcare Company, Inc. | 2.25B | 4.76% | 2,319,009 | 3.37B |
| 223 | VERA | Vera Therapeutics, Inc. | 2.24B | -7.90% | 1,716,141 | - |
| 224 | IMNM | Immunome, Inc. | 2.19B | -6.93% | 2,835,374 | 4.02M |
| 225 | PBH | Prestige Consumer Healthcare Inc. | 2.17B | -0.26% | 662,395 | 1.09B |
| 226 | ELVN | Enliven Therapeutics, Inc. | 2.16B | -5.31% | 1,810,518 | - |
| 227 | RARE | Ultragenyx Pharmaceutical Inc. | 2.14B | -4.68% | 2,029,030 | 670.00M |
| 228 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.12B | -2.68% | 4,510,976 | 885.72M |
| 229 | AXGN | Axogen, Inc. | 2.10B | 1.91% | 583,769 | 238.11M |
| 230 | LMAT | LeMaitre Vascular, Inc. | 2.09B | 0.22% | 273,326 | 256.28M |
| 231 | KOD | Kodiak Sciences Inc. | 2.07B | -10.01% | 836,888 | - |
| 232 | ESTA | Establishment Labs Holdings Inc. | 2.07B | 3.42% | 595,986 | 229.58M |
| 233 | SEM | Select Medical Holdings Corporation | 2.05B | -0.12% | 835,515 | 5.52B |
| 234 | PHVS | Pharvaris N.V. | 2.02B | -0.41% | 349,741 | - |
| 235 | HCM | HUTCHMED (China) Limited | 2.02B | 1.05% | 139,098 | 548.51M |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 1.98B | 0.52% | 1,304,499 | 298.30M |
| 237 | NKTR | Nektar Therapeutics | 1.98B | -8.30% | 2,151,365 | 55.63M |
| 238 | XRAY | DENTSPLY SIRONA Inc. | 1.97B | -1.90% | 5,957,477 | 3.68B |
| 239 | PGNY | Progyny, Inc. | 1.97B | -4.12% | 2,142,706 | 1.29B |
| 240 | CLOV | Clover Health Investments, Corp. | 1.96B | -4.85% | 5,946,766 | 2.21B |
| 241 | ZLAB | Zai Lab Limited | 1.93B | 0.35% | 1,769,012 | 453.28M |
| 242 | TRVI | Trevi Therapeutics, Inc. | 1.92B | -3.23% | 925,777 | - |
| 243 | RXRX | Recursion Pharmaceuticals, Inc. | 1.92B | -4.75% | 20,861,585 | 66.41M |
| 244 | MESO | Mesoblast Limited | 1.91B | -2.29% | 178,565 | 65.38M |
| 245 | OMCL | Omnicell, Inc. | 1.91B | -2.90% | 529,697 | 1.23B |
| 246 | NEOG | Neogen Corporation | 1.90B | -1.91% | 3,374,958 | 870.56M |
| 247 | ABCL | AbCellera Biologics Inc. | 1.87B | -5.11% | 8,065,308 | 79.21M |
| 248 | BHC | Bausch Health Companies Inc. | 1.87B | -5.65% | 3,975,013 | 10.53B |
| 249 | NBTX | Nanobiotix S.A. | 1.85B | -3.53% | 53,919 | 38.27M |
| 250 | NTLA | Intellia Therapeutics, Inc. | 1.83B | -4.37% | 3,945,311 | 66.09M |
| 251 | NVCR | NovoCure Limited | 1.83B | -4.47% | 1,390,345 | 674.41M |
| 252 | IOVA | Iovance Biotherapeutics, Inc. | 1.83B | 3.54% | 12,715,770 | 285.61M |
| 253 | ASTH | Astrana Health, Inc. | 1.83B | -2.25% | 408,767 | 3.53B |
| 254 | OCUL | Ocular Therapeutix, Inc. | 1.82B | -6.94% | 3,052,170 | 52.04M |
| 255 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -0.84% | 303,524 | 1.20B |
| 256 | CMPS | COMPASS Pathways plc | 1.80B | -6.06% | 5,390,580 | - |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 1.79B | -2.83% | 1,084,449 | 899.11M |
| 258 | STOK | Stoke Therapeutics, Inc. | 1.79B | -5.87% | 611,379 | 32.08M |
| 259 | SGRY | Surgery Partners, Inc. | 1.78B | 4.16% | 1,842,560 | 3.34B |
| 260 | ATAI | AtaiBeckley Inc. | 1.76B | -0.21% | 7,196,542 | 3.49M |
| 261 | ADMA | ADMA Biologics, Inc. | 1.76B | -3.80% | 3,279,836 | 509.86M |
| 262 | ZYME | Zymeworks Inc. | 1.76B | -1.75% | 887,665 | 81.26M |
| 263 | VCEL | Vericel Corporation | 1.76B | 4.95% | 940,700 | 292.09M |
| 264 | VRDN | Viridian Therapeutics, Inc. | 1.75B | -6.43% | 2,015,406 | 70.92M |
| 265 | MD | Pediatrix Medical Group, Inc. | 1.74B | 0.65% | 713,400 | 1.93B |
| 266 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | -7.72% | 4,609,962 | 2.18B |
| 267 | AAPG | Ascentage Pharma Group International | 1.71B | -3.30% | 2,049 | 82.08M |
| 268 | GHRS | GH Research PLC | 1.71B | 0.16% | 381,908 | - |
| 269 | NUVB | Nuvation Bio Inc. | 1.71B | -1.21% | 4,300,946 | 143.05M |
| 270 | TYRA | Tyra Biosciences, Inc. | 1.70B | -5.69% | 716,748 | - |
| 271 | NRIX | Nurix Therapeutics, Inc. | 1.69B | -5.87% | 1,050,537 | 71.78M |
| 272 | QURE | uniQure N.V. | 1.69B | -5.17% | 764,287 | 18.09M |
| 273 | PLSE | Pulse Biosciences, Inc. | 1.68B | -1.58% | 230,292 | 751.00K |
| 274 | NVAX | Novavax, Inc. | 1.68B | -2.85% | 4,652,960 | 596.34M |
| 275 | UFPT | UFP Technologies, Inc. | 1.68B | -0.73% | 169,675 | 608.85M |
| 276 | RAPP | Rapport Therapeutics, Inc. | 1.67B | -5.96% | 309,381 | 20.00M |
| 277 | ADUS | Addus HomeCare Corporation | 1.65B | 1.12% | 254,784 | 1.45B |
| 278 | SION | Sionna Therapeutics, Inc. | 1.65B | -10.81% | 537,838 | - |
| 279 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | -4.69% | 1,550,434 | 7.47M |
| 280 | SNDX | Syndax Pharmaceuticals, Inc. | 1.63B | -2.44% | 1,361,169 | 217.17M |
| 281 | CAPR | Capricor Therapeutics, Inc. | 1.58B | -4.17% | 895,795 | 11.13M |
| 282 | ANIP | ANI Pharmaceuticals, Inc. | 1.58B | -2.69% | 264,520 | 923.71M |
| 283 | WGS | GeneDx Holdings Corp. | 1.58B | 2.17% | 1,046,920 | 442.68M |
| 284 | AGIO | Agios Pharmaceuticals, Inc. | 1.58B | -5.32% | 1,100,884 | 66.05M |
| 285 | INVA | Innoviva, Inc. | 1.58B | -0.74% | 1,047,117 | 420.69M |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.57B | 2.75% | 832,537 | 367.34M |
| 287 | SLS | SELLAS Life Sciences Group, Inc. | 1.55B | -8.16% | 10,354,635 | - |
| 288 | GENB | Generate Biomedicines, Inc. | 1.53B | -7.71% | 1,223,320 | 30.30M |
| 289 | BHVN | Biohaven Ltd. | 1.53B | -11.37% | 2,329,545 | - |
| 290 | PRCT | PROCEPT BioRobotics Corporation | 1.52B | -3.95% | 919,412 | 322.02M |
| 291 | IMCR | Immunocore Holdings plc | 1.51B | 1.73% | 599,846 | 412.81M |
| 292 | PVLA | Palvella Therapeutics, Inc. | 1.50B | -7.03% | 200,402 | - |
| 293 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -9.81% | 973,738 | 42.95M |
| 294 | ANAB | AnaptysBio, Inc. | 1.49B | -3.54% | 819,848 | 232.39M |
| 295 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.48B | -5.54% | 1,650,922 | -665.00K |
| 296 | VIR | Vir Biotechnology, Inc. | 1.47B | -3.21% | 1,415,184 | 65.50M |
| 297 | MBX | MBX Biosciences, Inc. | 1.46B | 0.16% | 609,313 | - |
| 298 | FTRE | Fortrea Holdings Inc. | 1.45B | -2.54% | 1,372,371 | 2.71B |
| 299 | PRGO | Perrigo Company plc | 1.45B | -2.79% | 3,504,465 | 4.18B |
| 300 | AGL | agilon health, inc. | 1.45B | -6.26% | 299,433 | 5.82B |
| 301 | ALMR | Alamar Biosciences, Inc. | 1.44B | 1.41% | 57,345 | 87.16M |
| 302 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | - | 1,512,047 | 114.48M |
| 303 | STAA | STAAR Surgical Company | 1.42B | -3.59% | 615,688 | 290.38M |
| 304 | DMRA | Damora Therapeutics, Inc. | 1.41B | -7.65% | 288,657 | - |
| 305 | NNNN | Anbio Biotechnology | 1.41B | 6.46% | 13,470 | 8.65M |
| 306 | AVAH | Aveanna Healthcare Holdings Inc. | 1.41B | -3.00% | 3,022,448 | 2.52B |
| 307 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -2.48% | 794,920 | - |
| 308 | HCSG | Healthcare Services Group, Inc. | 1.39B | 1.50% | 684,495 | 1.85B |
| 309 | PGEN | Precigen, Inc. | 1.38B | -6.31% | 9,639,313 | 31.60M |
| 310 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -5.70% | 320,640 | 1.30M |
| 311 | ARDX | Ardelyx, Inc. | 1.36B | -3.66% | 4,149,219 | 427.68M |
| 312 | TDOC | Teladoc Health, Inc. | 1.36B | -4.68% | 5,025,825 | 2.51B |
| 313 | SEPN | Septerna, Inc. | 1.35B | -0.20% | 603,614 | 72.26M |
| 314 | IMTX | Immatics N.V. | 1.35B | -9.87% | 2,123,299 | 43.00M |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.34B | -4.60% | 198,593 | 20.00M |
| 316 | BLFS | BioLife Solutions, Inc. | 1.34B | 3.23% | 1,332,017 | 101.66M |
| 317 | SVRA | Savara Inc. | 1.33B | 1.94% | 1,943,292 | - |
| 318 | ARDT | Ardent Health, Inc. | 1.33B | 0.54% | 369,963 | 6.43B |
| 319 | NEO | NeoGenomics, Inc. | 1.32B | -3.07% | 1,060,538 | 745.97M |
| 320 | MLTX | MoonLake Immunotherapeutics | 1.32B | -5.05% | 1,119,750 | - |
| 321 | ATRC | AtriCure, Inc. | 1.31B | -2.34% | 649,457 | 552.16M |
| 322 | URGN | UroGen Pharma Ltd. | 1.29B | -1.81% | 758,499 | 140.49M |
| 323 | BCAX | Bicara Therapeutics Inc. | 1.29B | -4.75% | 669,224 | - |
| 324 | AHCO | AdaptHealth Corp. | 1.28B | -2.82% | 1,798,223 | 3.29B |
| 325 | TNDM | Tandem Diabetes Care, Inc. | 1.27B | -2.72% | 1,428,358 | 1.03B |
| 326 | ENOV | Enovis Corporation | 1.26B | 1.11% | 1,338,407 | 2.28B |
| 327 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.25B | 1.68% | 2,560,046 | 204.73M |
| 328 | AHG | Akso Health Group | 1.24B | -2.68% | 17,611 | 14.84M |
| 329 | MPLT | MapLight Therapeutics, Inc. | 1.24B | -8.13% | 467,773 | - |
| 330 | HROW | Harrow, Inc. | 1.22B | -3.66% | 587,787 | 268.68M |
| 331 | IART | Integra LifeSciences Holdings Corporation | 1.22B | - | 1,143,156 | 1.64B |
| 332 | COAG | Hemab Therapeutics Holdings, Inc. | 1.21B | 1.25% | 194,536 | - |
| 333 | BFLY | Butterfly Network, Inc. | 1.20B | -0.43% | 2,759,566 | 102.92M |
| 334 | AMN | AMN Healthcare Services, Inc. | 1.17B | 3.10% | 1,057,409 | 3.42B |
| 335 | AVNS | Avanos Medical, Inc. | 1.17B | -0.24% | 3,246,307 | 715.90M |
| 336 | INSP | Inspire Medical Systems, Inc. | 1.17B | -0.64% | 1,027,707 | 915.25M |
| 337 | PSNL | Personalis, Inc. | 1.17B | -1.07% | 2,422,034 | 64.52M |
| 338 | PAHC | Phibro Animal Health Corporation | 1.16B | -4.52% | 263,223 | 1.50B |
| 339 | ATEC | Alphatec Holdings, Inc. | 1.15B | - | 2,077,693 | 787.08M |
| 340 | IRMD | IRADIMED CORPORATION | 1.15B | -2.38% | 147,028 | 86.28M |
| 341 | CDNA | CareDx, Inc. | 1.14B | -3.20% | 904,001 | 412.82M |
| 342 | AKTS | Aktis Oncology, Inc. | 1.12B | 4.00% | 310,061 | 8.28M |
| 343 | SDGR | Schrödinger, Inc. | 1.12B | -5.44% | 1,231,886 | 254.91M |
| 344 | KMTS | Kestra Medical Technologies, Ltd. | 1.10B | -6.79% | 317,987 | 83.72M |
| 345 | WVE | Wave Life Sciences Ltd. | 1.09B | -9.11% | 4,439,891 | 71.80M |
| 346 | ZBIO | Zenas BioPharma, Inc. | 1.08B | -5.72% | 633,773 | 10.00M |
| 347 | AZTA | Azenta, Inc. | 1.08B | 1.03% | 1,044,247 | 596.48M |
| 348 | AVLN | Avalyn Pharma Inc. | 1.08B | -3.53% | 149,939 | - |
| 349 | PNTG | The Pennant Group, Inc. | 1.07B | -3.56% | 272,272 | 1.02B |
| 350 | MNKD | MannKind Corporation | 1.06B | -2.83% | 4,030,448 | 360.78M |
| 351 | OMDA | Omada Health, Inc. | 1.06B | -3.21% | 1,216,944 | 283.30M |
| 352 | OPK | OPKO Health, Inc. | 1.06B | - | 3,435,441 | 581.12M |
| 353 | EVO | Evotec SE | 1.05B | -3.91% | 39,558 | 859.03M |
| 354 | DBVT | DBV Technologies S.A. | 1.05B | -3.03% | 251,662 | 5.74M |
| 355 | EYPT | EyePoint, Inc. | 1.05B | -4.71% | 882,268 | 7.61M |
| 356 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | -1.15% | 1,408,574 | 314.85M |
| 357 | CNMD | CONMED Corporation | 1.02B | -2.31% | 737,847 | 1.37B |
| 358 | CRON | Cronos Group Inc. | 1.02B | -3.19% | 798,442 | 159.54M |
| 359 | GDRX | GoodRx Holdings, Inc. | 999.09M | -4.22% | 1,446,926 | 787.89M |
| 360 | AORT | Artivion, Inc. | 991.26M | -2.99% | 662,094 | 458.69M |
| 361 | ABSI | Absci Corporation | 990.00M | -2.61% | 3,690,542 | 1.84M |
| 362 | COLL | Collegium Pharmaceutical, Inc. | 988.58M | -4.09% | 668,658 | 796.33M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 983.02M | -3.23% | 1,912,726 | - |
| 364 | INNV | InnovAge Holding Corp. | 980.02M | -1.10% | 394,042 | 949.17M |
| 365 | USPH | U.S. Physical Therapy, Inc. | 951.17M | -0.05% | 139,470 | 787.69M |
| 366 | CGEM | Cullinan Therapeutics, Inc. | 942.77M | -5.37% | 1,290,378 | - |
| 367 | ALVO | Alvotech | 939.06M | -6.83% | 1,311,140 | 562.04M |
| 368 | OLMA | Olema Pharmaceuticals, Inc. | 933.74M | -15.89% | 2,737,349 | - |
| 369 | SPTX | Seaport Therapeutics, Inc. | 912.61M | 0.47% | 87,794 | - |
| 370 | QDEL | QuidelOrtho Corporation | 906.26M | 0.15% | 1,463,674 | 2.66B |
| 371 | SANA | Sana Biotechnology, Inc. | 901.66M | 0.93% | 3,216,732 | - |
| 372 | PHAR | Pharming Group N.V. | 884.46M | -6.26% | 22,567 | 369.49M |
| 373 | SPRY | ARS Pharmaceuticals, Inc. | 883.80M | -5.62% | 1,853,304 | 98.99M |
| 374 | JBIO | Jade Biosciences, Inc. | 876.14M | -4.52% | 993,324 | - |
| 375 | PCRX | Pacira BioSciences, Inc. | 875.49M | -3.09% | 345,434 | 734.86M |
| 376 | AVR | Anteris Technologies Global Corp. | 874.50M | 2.09% | 975,681 | 1.85M |
| 377 | TALK | Talkspace, Inc. | 874.42M | -0.19% | 1,389,582 | 238.37M |
| 378 | CERT | Certara, Inc. | 874.27M | -8.17% | 2,178,514 | 419.75M |
| 379 | ANNX | Annexon, Inc. | 861.81M | -5.73% | 2,105,072 | - |
| 380 | NUTX | Nutex Health Inc. | 860.37M | -2.34% | 173,921 | 879.95M |
| 381 | MGTX | MeiraGTx Holdings plc | 855.71M | -5.71% | 790,893 | 79.76M |
| 382 | INMD | InMode Ltd. | 855.34M | -0.66% | 573,827 | 374.64M |
| 383 | ABUS | Arbutus Biopharma Corporation | 841.51M | -4.91% | 1,750,124 | 191.45M |
| 384 | JANX | Janux Therapeutics, Inc. | 840.36M | -4.37% | 704,370 | 13.73M |
| 385 | LXRX | Lexicon Pharmaceuticals, Inc. | 839.53M | -8.70% | 3,157,363 | 69.64M |
| 386 | XNCR | Xencor, Inc. | 831.13M | -5.00% | 595,388 | 97.36M |
| 387 | IVA | Inventiva S.A. | 829.57M | -14.26% | 2,606,161 | 7.94M |
| 388 | AMPH | Amphastar Pharmaceuticals, Inc. | 813.51M | 0.16% | 810,643 | 720.53M |
| 389 | ESPR | Esperion Therapeutics, Inc. | 808.34M | 0.32% | 14,043,530 | 418.24M |
| 390 | DRTS | Alpha Tau Medical Ltd. | 805.27M | -7.65% | 1,085,187 | - |
| 391 | TBPH | Theravance Biopharma, Inc. | 803.20M | -2.26% | 814,822 | 109.78M |
| 392 | SSII | SS Innovations International, Inc. | 801.76M | 1.78% | 124,693 | 48.47M |
| 393 | ODTX | Odyssey Therapeutics, Inc. | 798.66M | -0.18% | 451,195 | 2.98M |
| 394 | KURA | Kura Oncology, Inc. | 796.31M | -0.77% | 2,658,887 | 71.64M |
| 395 | ORIC | ORIC Pharmaceuticals, Inc. | 788.80M | -15.14% | 3,880,237 | - |
| 396 | LBRX | LB Pharmaceuticals Inc | 774.84M | -3.60% | 147,290 | - |
| 397 | PHAT | Phathom Pharmaceuticals, Inc. | 766.50M | 4.44% | 1,864,585 | 204.89M |
| 398 | AURA | Aura Biosciences, Inc. | 761.07M | -4.03% | 479,959 | - |
| 399 | DRUG | Bright Minds Biosciences Inc. | 757.92M | -5.23% | 509,085 | - |
| 400 | GERN | Geron Corporation | 750.58M | -3.31% | 13,031,718 | 196.12M |
| 401 | ETON | Eton Pharmaceuticals, Inc. | 750.55M | -4.46% | 422,444 | 86.93M |
| 402 | OMER | Omeros Corporation | 742.57M | -4.29% | 2,440,865 | 9.89M |
| 403 | OCS | Oculis Holding AG | 742.17M | -15.30% | 3,110,679 | 1.40M |
| 404 | VOR | Vor Biopharma Inc. | 740.18M | -6.25% | 799,166 | - |
| 405 | HSTM | HealthStream, Inc. | 736.81M | -1.45% | 250,735 | 311.78M |
| 406 | BIOA | BioAge Labs, Inc. | 735.25M | -3.84% | 382,380 | 10.32M |
| 407 | AVTX | Avalo Therapeutics, Inc. | 733.82M | -11.37% | 1,604,167 | 59.00K |
| 408 | REPL | Replimune Group, Inc. | 732.42M | -1.44% | 6,207,350 | - |
| 409 | LMRI | Lumexa Imaging Holdings, Inc. | 721.57M | 2.18% | 468,566 | 1.03B |
| 410 | EVMN | Evommune, Inc. | 713.88M | -10.60% | 388,264 | 10.00M |
| 411 | ALLO | Allogene Therapeutics, Inc. | 707.57M | -4.65% | 7,373,756 | 22.00K |
| 412 | CTMX | CytomX Therapeutics, Inc. | 687.94M | -8.41% | 4,927,782 | 35.54M |
| 413 | BVS | Bioventus Inc. | 677.47M | 2.27% | 1,128,325 | 576.30M |
| 414 | RLMD | Relmada Therapeutics, Inc. | 673.40M | -6.28% | 1,909,609 | - |
| 415 | CBLL | CeriBell, Inc. | 664.00M | -0.62% | 262,465 | 95.07M |
| 416 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 662.49M | -3.27% | 135,539 | - |
| 417 | ANRO | Alto Neuroscience, Inc. | 655.84M | -5.51% | 321,145 | - |
| 418 | SLDB | Solid Biosciences Inc. | 647.80M | -8.48% | 1,581,584 | - |
| 419 | ACRS | Aclaris Therapeutics, Inc. | 646.64M | 6.68% | 1,510,153 | 8.37M |
| 420 | TENX | Tenax Therapeutics, Inc. | 644.72M | -8.52% | 936,439 | - |
| 421 | ZVRA | Zevra Therapeutics, Inc. | 643.17M | -5.31% | 1,539,084 | 122.29M |
| 422 | TLRY | Tilray Brands, Inc. | 641.74M | -2.00% | 2,463,149 | 858.28M |
| 423 | CRMD | CorMedix Inc. | 640.95M | -3.31% | 964,191 | 400.05M |
| 424 | PHR | Phreesia, Inc. | 640.37M | -2.81% | 1,885,756 | 495.59M |
| 425 | DSGN | Design Therapeutics, Inc. | 635.19M | -2.59% | 1,052,617 | - |
| 426 | SIBN | SI-BONE, Inc. | 621.33M | 1.01% | 480,352 | 206.22M |
| 427 | CADL | Candel Therapeutics, Inc. | 616.94M | -1.06% | 1,722,993 | - |
| 428 | SGP | SpyGlass Pharma, Inc. | 613.71M | 0.22% | 41,586 | - |
| 429 | DNA | Ginkgo Bioworks Holdings, Inc. | 609.48M | 2.08% | 2,881,061 | 151.40M |
| 430 | CABA | Cabaletta Bio, Inc. | 600.04M | 0.27% | 3,441,712 | - |
| 431 | CSTL | Castle Biosciences, Inc. | 597.80M | -6.01% | 459,806 | 339.92M |
| 432 | BWAY | BrainsWay Ltd. | 583.98M | -5.70% | 214,315 | 56.22M |
| 433 | IMMX | Immix Biopharma, Inc. | 583.80M | -9.27% | 1,380,406 | - |
| 434 | PRME | Prime Medicine, Inc. | 579.78M | -5.59% | 3,311,841 | 4.03M |
| 435 | AGMB | AgomAb Therapeutics NV | 579.65M | 2.88% | 51,887 | - |
| 436 | PROK | ProKidney Corp. | 573.91M | 2.70% | 2,258,394 | 889.00K |
| 437 | BBNX | Beta Bionics, Inc. | 569.94M | -0.08% | 900,372 | 110.24M |
| 438 | CBIO | Crescent Biopharma, Inc. | 565.06M | -13.77% | 437,081 | 11.88M |
| 439 | ALT | Altimmune, Inc. | 563.98M | -3.65% | 3,144,481 | 36.00K |
| 440 | TRAX | First Tracks Biotherapeutics, Inc. | 563.16M | -10.78% | 720,338 | - |
| 441 | RIGL | Rigel Pharmaceuticals, Inc. | 555.43M | 0.54% | 405,849 | 299.77M |
| 442 | NPCE | NeuroPace, Inc. | 555.39M | -1.33% | 203,329 | 99.53M |
| 443 | TCMD | Tactile Systems Technology, Inc. | 550.60M | 1.79% | 193,043 | 343.52M |
| 444 | SRTA | Strata Critical Medical, Inc. | 541.66M | 2.29% | 679,725 | 228.58M |
| 445 | CTKB | Cytek Biosciences, Inc. | 541.11M | -1.18% | 803,437 | 204.17M |
| 446 | CERS | Cerus Corporation | 541.00M | -4.93% | 2,435,176 | 216.56M |
| 447 | IRWD | Ironwood Pharmaceuticals, Inc. | 539.93M | -5.20% | 1,900,427 | 361.51M |
| 448 | CLYM | Climb Bio, Inc. | 535.01M | -5.08% | 1,370,188 | - |
| 449 | MDXG | MiMedx Group, Inc. | 531.74M | -0.28% | 1,173,744 | 389.42M |
| 450 | FLGT | Fulgent Genetics, Inc. | 531.09M | 3.37% | 738,203 | 320.35M |
| 451 | VALN | Valneva SE | 528.88M | -5.38% | 38,628 | 180.25M |
| 452 | XOMA | XOMA Royalty Corporation | 522.84M | - | 79,459 | 48.56M |
| 453 | EIKN | Eikon Therapeutics, Inc. | 519.46M | -11.08% | 219,613 | - |
| 454 | TECX | Tectonic Therapeutic, Inc. | 517.58M | -5.05% | 189,503 | - |
| 455 | ACHV | Achieve Life Sciences, Inc. | 516.38M | -5.09% | 866,398 | - |
| 456 | ARVN | Arvinas, Inc. | 516.17M | -6.76% | 845,449 | 89.40M |
| 457 | GYRE | Gyre Therapeutics, Inc. | 508.03M | -4.30% | 120,673 | 117.05M |
| 458 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 459 | AQST | Aquestive Therapeutics, Inc. | 493.02M | -1.75% | 1,972,237 | 50.27M |
| 460 | PACB | Pacific Biosciences of California, Inc. | 490.75M | - | 7,936,273 | 160.03M |
| 461 | ASMB | Assembly Biosciences, Inc. | 485.32M | -9.03% | 276,588 | 71.10M |
| 462 | FDMT | 4D Molecular Therapeutics, Inc. | 484.60M | -4.53% | 895,596 | 88.24M |
| 463 | CTEV | Claritev Corporation | 483.13M | 5.00% | 131,117 | 978.76M |
| 464 | PRTA | Prothena Corporation plc | 481.13M | -4.17% | 438,910 | 57.94M |
| 465 | WEAV | Weave Communications, Inc. | 479.78M | -6.94% | 1,129,388 | 248.72M |
| 466 | KYTX | Kyverna Therapeutics, Inc. | 478.19M | -3.89% | 1,614,255 | - |
| 467 | CCCC | C4 Therapeutics, Inc. | 478.18M | -0.91% | 4,006,605 | 34.86M |
| 468 | AUTL | Autolus Therapeutics plc | 465.75M | -4.89% | 1,167,371 | 92.62M |
| 469 | ANL | Adlai Nortye Ltd. | 463.20M | -3.74% | 71,721 | 5.00M |
| 470 | CTNM | Contineum Therapeutics, Inc. | 462.84M | -5.42% | 242,293 | - |
| 471 | TOI | The Oncology Institute, Inc. | 458.92M | -3.97% | 1,161,790 | 545.76M |
| 472 | ANGO | AngioDynamics, Inc. | 457.46M | 0.60% | 284,202 | 313.73M |
| 473 | MOBI | Mobia Medical, Inc. | 455.92M | 2.07% | 940,730 | 32.04M |
| 474 | OCGN | Ocugen, Inc. | 453.62M | -2.19% | 4,377,660 | 4.47M |
| 475 | LAB | Standard BioTools Inc. | 452.83M | 0.87% | 3,885,500 | 86.26M |
| 476 | OVID | Ovid Therapeutics Inc. | 447.94M | -6.25% | 1,416,711 | 7.12M |
| 477 | EVH | Evolent Health, Inc. | 445.43M | -5.04% | 2,333,391 | 1.89B |
| 478 | FBRX | Forte Biosciences, Inc. | 444.12M | -5.54% | 367,564 | - |
| 479 | NRC | NRC Health | 442.62M | -3.01% | 110,272 | 138.64M |
| 480 | EPRX | Eupraxia Pharmaceuticals Inc. | 436.96M | -3.06% | 296,506 | - |
| 481 | KMDA | Kamada Ltd. | 435.56M | -2.47% | 49,776 | 181.68M |
| 482 | EDIT | Editas Medicine, Inc. | 432.76M | -15.57% | 3,919,068 | 38.69M |
| 483 | KIDS | OrthoPediatrics Corp. | 431.76M | 0.96% | 124,210 | 243.30M |
| 484 | CNXU | Conexeu Sciences Inc. | 425.55M | 19.26% | 288,900 | - |
| 485 | EBS | Emergent BioSolutions Inc. | 423.61M | -3.30% | 802,436 | 676.80M |
| 486 | SGMT | Sagimet Biosciences Inc. | 419.29M | -5.56% | 923,475 | - |
| 487 | VREX | Varex Imaging Corporation | 418.94M | -0.90% | 408,552 | 857.50M |
| 488 | RZLT | Rezolute, Inc. | 417.87M | 10.80% | 6,754,204 | - |
| 489 | NGNE | Neurogene Inc. | 413.06M | -5.08% | 107,357 | 925.00K |
| 490 | CATX | Perspective Therapeutics, Inc. | 410.57M | -1.64% | 1,006,164 | 618.00K |
| 491 | MNPR | Monopar Therapeutics Inc. | 410.37M | -5.30% | 103,129 | - |
| 492 | VTVT | vTv Therapeutics Inc. | 409.45M | -3.80% | 24,091 | 36.84M |
| 493 | MYGN | Myriad Genetics, Inc. | 407.07M | 0.70% | 2,380,596 | 829.00M |
| 494 | EOLS | Evolus, Inc. | 406.32M | -5.37% | 521,261 | 301.79M |
| 495 | CCRN | Cross Country Healthcare, Inc. | 405.90M | - | 254,225 | 1.00B |
| 496 | STRO | Sutro Biopharma, Inc. | 404.82M | -13.52% | 332,360 | 99.61M |
| 497 | CGC | Canopy Growth Corporation | 404.80M | -1.85% | 6,385,445 | 203.04M |
| 498 | ADCT | ADC Therapeutics SA | 403.20M | -6.76% | 796,769 | 79.18M |
| 499 | UPB | Upstream Bio, Inc. | 394.54M | -10.27% | 632,583 | 3.32M |
| 500 | OFIX | Orthofix Medical Inc. | 392.49M | 4.75% | 529,170 | 825.37M |